Observational studyAnnals of hematology2024

CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia.

Heba A Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.